Hypercholesterolemia, Familial Clinical Trial
Official title:
Non-interventional Study: Safety and Efficacy of the DALI LDL-adsorber and MONET-lipoprotein Filter
Low Density Lipoprotein (LDL)-apheresis refers to a procedure in which blood taken from a patient's vein is cleaned from pathogenic substances, e.g. cholesterol, outside the body and then given back to the patient. In the DALI (Direct Adsorption of Lipoproteins)-system whole blood is pumped over an adsorber containing beads that selectively bind LDL-cholesterol. The MONET (Membrane filtration Optimized Novel Extracorporeal Treatment)-system works with plasma which is cleaned by filtration. This study comprises the recording of safety and efficacy data from patients treated either with the DALI or MONET-system over a period of 2 years.
Data were recorded from patients suffering from familial hypercholesterolemia and treated by lipid apheresis using one of the two systems investigated for at least 3 months prior to inclusion in the study. Only those treatments were documented in which routine blood samples for laboratory analysis were taken, or in which adverse or serious adverse device effects occur. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00384293 -
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
|
Phase 3 | |
| Completed |
NCT04722068 -
Regeneron 1331 Kinetics Sub-Study HoFH
|
N/A | |
| Completed |
NCT04118348 -
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
|
N/A | |
| Completed |
NCT00000594 -
NHLBI Type II Coronary Intervention Study
|
Phase 3 | |
| Completed |
NCT04526457 -
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
|
N/A | |
| Completed |
NCT03018678 -
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
|
||
| Completed |
NCT00134511 -
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
|
Phase 3 | |
| Completed |
NCT00134485 -
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
|
Phase 3 | |
| Recruiting |
NCT04073797 -
PET Imaging of Inflammation and Lipid Lowering Study
|
N/A | |
| Terminated |
NCT01583647 -
A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)
|
Phase 1 | |
| Completed |
NCT00515307 -
Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia
|
Phase 1 | |
| Recruiting |
NCT04656028 -
Genetic Testing and Motivational Counseling for FH
|
N/A | |
| Terminated |
NCT00092833 -
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
|
Phase 3 | |
| Active, not recruiting |
NCT04837638 -
Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia
|
||
| Completed |
NCT00280995 -
Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
|
Phase 2 | |
| Completed |
NCT06231459 -
Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia
|
Phase 4 | |
| Completed |
NCT01524289 -
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
|
Phase 3 | |
| Completed |
NCT00281008 -
Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
|
Phase 2 | |
| Recruiting |
NCT03989167 -
Clinical Decision Support for Familial Hypercholesterolemia
|
N/A | |
| Completed |
NCT03795038 -
Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI
|
N/A |